New Insights on How CRISPR/Cas9 can Treat People With Huntington's Disease
New improvements to gene-editing techniques such as CRISPR/Cas9 may hold promise for inactivating the defective gene responsible for developing Huntington's chorea, finds a new study.
No comments:
Post a Comment